Gregory Venn - NexCore Healthcare CEO and President and Director
CEO
Mr. Gregory C. Venn is Chief Executive Officer and Director of Nexcore Healthcare Capital Corporationration Prior to the Acquisition, he served as Chief Executive Officer of NexCore Group LP from its inception in May 2004 until the Acquisition. He was Senior Vice President of The Neenan Company from August 1990 to May 2004. He has developed andor managed projects ranging in size from 30, 000 to 300, 000 square feet and from 10 million to 100 million. His background includes architecture and planning, finance, real estate brokerage, business administration, and construction management since 2010.
Age | 51 |
Tenure | 14 years |
Professional Marks | MBA |
Phone | 303-244-0700 |
Web | http://www.nexcoregroup.com |
NexCore Healthcare Management Efficiency
The company has return on total asset (ROA) of 89.31 % which means that it generated a profit of $89.31 on every $100 spent on assets. This is very large. NexCore Healthcare's management efficiency ratios could be used to measure how well NexCore Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 1.3 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. NexCore Healthcare has a current ratio of 3.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist NexCore Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, NexCore Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NexCore Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NexCore to invest in growth at high rates of return. When we think about NexCore Healthcare's use of debt, we should always consider it together with cash and equity.
Similar Executives
Found 10 records | CEO Age | ||
William Johnson | PGE Corp | 65 | |
John Ketchum | Nextera Energy | 53 | |
William Smith | PGE Corp | 62 | |
Sanjeev Luther | Eterna Therapeutics | 62 | |
Charles Prober | NETGEAR | 53 | |
Ugur MD | BioNTech SE | 59 | |
Armando Pimentel | Nextera Energy | 61 | |
Patricia Poppe | PGE Corp | 55 | |
Bill Smith | PGE Corp | 61 | |
Rebecca Kujawa | Nextera Energy | 48 |
Management Performance
Return On Asset | 89.31 |
NexCore Healthcare Leadership Team
Elected by the shareholders, the NexCore Healthcare's board of directors comprises two types of representatives: NexCore Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NexCore. The board's role is to monitor NexCore Healthcare's management team and ensure that shareholders' interests are well served. NexCore Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NexCore Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Greg Hundley, Executive VP and General Counsel | ||
Richard Bloom, Independent Director | ||
Loren Snyder, Independent Director | ||
Gregory Venn, CEO and President and Director | ||
Robert Lawless, CFO and Principal Accounting Officer | ||
Peter Kloepfer, Chief Investment Officer, Corporate Secretary and Director | ||
Brian Klemsz, Independent Director |
NexCore Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is NexCore Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | 89.31 | |||
Profit Margin | 9.12 % | |||
Operating Margin | 71.59 % | |||
Current Valuation | (10.59 M) | |||
Shares Outstanding | 53.04 M | |||
Price To Earning | 0.71 X | |||
Price To Book | 0.17 X | |||
Price To Sales | 0.07 X | |||
Revenue | 39.31 M | |||
Gross Profit | 4.15 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NexCore Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NexCore Healthcare's short interest history, or implied volatility extrapolated from NexCore Healthcare options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the NexCore Healthcare information on this page should be used as a complementary analysis to other NexCore Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in NexCore Pink Sheet
If you are still planning to invest in NexCore Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NexCore Healthcare's history and understand the potential risks before investing.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |